Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study Says Only Half Of Chinese With HIV/AIDS Have Drug Access

This article was originally published in PharmAsia News

Executive Summary

Researchers in China have concluded that half of the nation's 700,000 HIV/AIDS patients have ceased drug treatments, most because they no longer have access to the medicines. Research carried out by China's CDC said the results are consistent with other reports of access in low- and middle-income countries. Under a government program launched in 2002, patients were to have access to drugs for free, but that plan failed to treat half the eligible group through 2008. The primary drugs used are GlaxoSmithKline's Retrovir (zidovudine) andEpivir (lamivudine), and Boehringer Ingelheim's Viramune (nevirapine). (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072512

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel